Bill & Melinda Gates Foundation’s “Impatient Optimists”: Innovation: Taking the Neglect out of Neglected Diseases, Part II
Trevor Mundel, president of global health at the Bill & Melinda Gates Foundation, discusses innovative research for onchocerciasis treatments and references a blog post he wrote last year on the topic. In his more recent post, Mundel discusses the research of Sara Lustigman, which is focused on understanding the parasite that causes onchocerciasis (10/31).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.